ChromaDex (CDXC) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Pre-Open Stock Movers 03/10: (MNOV) (KOSS) (CDXC) Higher; (TUP) (AVID) (JNCE) Lower (more...)
March 10, 2021 9:29 AM ESTToday's Pre-Open Stock Movers:
MediciNova, Inc. (NASDAQ: MNOV) 77.6% HIGHER; announced it has partnered with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to repurpose MN-166 (ibudilast) as a potential medical countermeasure (MCM) against chlorine gas-induced lung damage such as acute respiratory distress syndrome (ARDS) and acute lung injury (ALI). Under the Division of Research, Innovation, and Ventures (DRIVe) Repurposing Drugs in Response to Chemical Threats (ReDIRECT)... More
ChromaDex (CDXC) Announces Retail Distribution of Tru Niagen in Walmart Stores Across the United States
March 10, 2021 6:36 AM ESTChromaDex Corp. (NASDAQ: CDXC) announced today its flagship consumer product and industry-leading NAD+ booster Tru Niagen® will be available in 3,000 Walmart retail stores across the United States beginning June 2021. ChromaDex will introduce Tru Niagen® in two packaging options for Walmart customers, which will have distinct serving sizes and price points. In addition to in-store availability, these two options will be... More
ChromaDex (CDXC) PT Raised to $18 at B.Riley
March 9, 2021 8:27 AM ESTB.Riley analyst Jeff Van Sinderen raised the price target on ChromaDex (NASDAQ: CDXC) to $18.00 (from $7.00) while maintaining a Buy rating.... More
